Applied Evidence

The role of home BP monitoring: Answers to 10 common questions

Author and Disclosure Information

 

References

As the volume of patient-generated home data increases, there is a risk of information overload. Thus, meaningful summarization of the data is required to enable the physician, patient, and/or pharmacist to take prompt and effective action.

CORRESPONDENCE
Sonal J. Patil, MD, MSPH, Curtis W. and Ann H. Long Department of Family and Community Medicine, University of Missouri, MA306 Medical Sciences Building, DC032.00 Columbia, MO 65212; patilso@health.missouri.edu.

ACKNOWLEDGEMENTS
The authors are grateful to Dr. David R. Mehr for his valuable expertise in editing and proofreading this manuscript.

Pages

Recommended Reading

Obesity paradox applies to post-stroke mortality
MDedge Family Medicine
Sleep: Too much, too little both tied to atherosclerosis
MDedge Family Medicine
Ezetimibe found effective for primary prevention in elderly
MDedge Family Medicine
Subclinical hypothyroidism boosts immediate risk of heart failure
MDedge Family Medicine
Meta-analysis supports aspirin to reduce cardiovascular events
MDedge Family Medicine
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
MDedge Family Medicine
Lessons learned from the PCSK9 inhibitor trials
MDedge Family Medicine
CABANA: Ablation surpassed drugs for raising AF quality of life
MDedge Family Medicine
FDA: Nitrosamine-contaminated ARBs marketed for 4 years
MDedge Family Medicine
PCSK9 inhibition isn’t the answer for high Lp(a)
MDedge Family Medicine